Skip to main content
Caplight Logo









Toxometris

Toxometris

Private
United StatesHealthcare & Life Scienceshttps://toxometris.ai/

Last Round

Pre Seed

Nov 6, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Toxometris operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Pre Seed round in November 2023.

Toxometris is a biotechnology company that provides AI-powered in silico toxicology screening services for drug discovery and chemical development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Compliance & Risk, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Toxometris Comparables

Compare Toxometris with similar companies based on industry and business-model similarity.

Toxometris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axiom Bio
86%
MultiCASE Inc.
83%
Greenstone Biosciences
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Toxometris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 6, 2023
AcceleratorJan 25, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Toxometris Investors

Notable investors and investment history

Toxometris investors
InvestorRounds
Armenia Startup AcademyAccelerator
SmartGateVCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 721% MoM, from 295 to 2.4K.

  • Oct 18, 2024

    Grew 100% QoQ from 3 to 6 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Toxometris Filings

Explore SEC and related filing metadata, where available.

Toxometris filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Toxometris's valuation, stock price, and market status.

Is Toxometris a public or private company?

Toxometris is a private company.

What is the current stock price of Toxometris?

Toxometris is a private company, so its shares have no public market price. Caplight tracks Toxometris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Toxometris worth (valuation)?

Valuation information for Toxometris is not publicly available.

Can I buy Toxometris stock?

Toxometris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Toxometris's last funding round?

Toxometris's most recent funding round was Pre Seed on November 6, 2023.

Who are the main investors in Toxometris?

Key investors in Toxometris include SmartGateVC.

Will Toxometris IPO soon?

No public IPO plans have been announced for Toxometris.

How can I track Toxometris secondary market activity?

Caplight tracks bids, offers, and trades in Toxometris's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Employee Range5
Year FoundedN/A
Last FundingNov 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?